Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.04 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.091 | 0.05 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.088 | 0.07 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |